The DEA is not bound to follow the U.S. Health and Human Services Department’s recommendation to reclassify marijuana as a Schedule III drug.
You are here: Home / Top Stories / Cannabis Watch: HHS recommendation to reschedule cannabis keeps pot stocks hot, but questions remain